A Study of Novel Study Interventions and Combinations in Participants with Colorectal Cancer

Trial Identifier: D798VC00001
Sponsor: AstraZeneca
Collaborator:
Parexel
Start Date: March 2025
Primary Completion Date: March 2027
Study Completion Date: January 2028
Condition: Colorectal Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU East Melbourne, AU, 3002
AU Wollongong, AU, 2500
CA, BC Victoria, BC, CA, V8R 6V5
CA, ON Toronto, ON, CA, M5G 1X6
CA, Ontario Barrie, Ontario, CA, L4M 6M2
CA, QC Montreal, QC, CA, H3T 1E2
CN Beijing, CN, 100142
CN Harbin, CN, 150081
CN Shanghai, CN, 200032
CN Zhengzhou City, CN, 450000
DE Berlin, DE, 10117
DE Dresden, DE, 01307
DE Essen, DE, 45147
DE Hamburg, DE, 22763
DE Marburg, DE, 35043
ES Barcelona, ES, 08035
ES Madrid, ES, 28007
ES Madrid, ES, 28034
ES Madrid, ES, 28041
ES Malaga, ES, 29010
ES Pamplona, ES, 31005
ES Santander, ES, 39008
ES València, ES, 46010
FR Bordeaux, FR, 33076
FR Montpellier, FR, 34090
FR Montpellier, FR, 34298
FR POITIERS, FR, 86021
FR Saint-Priez en Jarez, FR, 42270
FR Villejuif Cedex, FR, 94805
GB Cambridge, GB, CB2 0XY
GB London, GB, W12 0HS
GB London, GB, NW1 2PG
GB Manchester, GB, M20 4GJ
GB Wirral, GB, CH63 4JY
IT Firenze, IT, 50134
IT Milano, IT, 20162
IT Milano, IT, 20133
IT Napoli, IT, 80131
IT Pavia, IT, 27100
IT Roma, IT, 00168
KR Seoul, KR, 06351
KR Seoul, KR, 06591
KR Seoul, KR, 03080
KR Seoul, KR, 5505
KR Yongin-si, KR, 16995
TW Kaohsiung, TW, 80756
TW Taipei, TW, 10002
TW Taoyuan, TW, 333
TW Yung Kang City, TW, 71044
US, AZ Scottsdale, AZ, US, 85259
US, CA Los Angeles, CA, US, 90089
US, DC Washington, DC, US, 20007
US, IL Chicago, IL, US, 60637
US, MA Boston, MA, US, 02114
US, MD Baltimore, MD, US, 21224
US, MN Rochester, MN, US, 55905
US, NY Rochester, NY, US, 14618
US, OH Cleveland, OH, US, 44106
US, TX Houston, TX, US, 77030